Sarepta Therapeutics, Inc. - 8-K Filing
On June 4, 2026, Sarepta Therapeutics held its annual meeting where stockholders approved the 2026 Equity Incentive Plan and the 2026 Employee Stock Purchase Plan. The equity plan allows for up to 6,740,000 shares of common stock to be issued through awards, while the ESPP provides for up to 1,500,000 shares available for issuance. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $SRPT